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Abstract— Repolarization alternans is related to the initiation
of life threatening cardiac arrhythmias. Experimental and
computational studies suggest that the abolishment of alternans
using dynamic pacing protocols may prevent abnormal heart
rhythms. In a recent animal study, refractory period pacing
(RPP) on every other beat has shown promising results in
alternans reduction. However, the cellular mechanisms under-
lying this therapy and its efficiency in human patients remain
unclear. In this study, in vivo unipolar electrograms acquired
during RPP from 240 epicardial sites from one patient were
analysed. Current clamp of 18 channels was performed in silico
to elucidate the ionic mechanisms underlying action potential
modulation by RPP. Its efficacy with positive and negative
polarities was tested on a population of 87 calibrated human
ventricular models exhibiting alternans. In vivo electrograms
showed significant changes in T-wave alternans when applying
RPP. In silico, results showed APD shortening for RPP with
positive polarity and APD prolongation with RPP negative.
Under current clamp protocols, voltage rectification of L-type
Ca2+ (ICaL) and inward rectifier K+ (IK1) currents were
identified as the key determinants for the observed changes.
RPP pacing successfully reduced alternans on the in silico
models using a negative polarity stimulus in the short beat.
I. INTRODUCTION
T-wave alternans (TWA) are characterized as a beat-to
beat oscillation on the morphology of the ST-segment or T-
wave on electrocardiograms (ECG). Since the T-wave is a
representation of ventricular repolarization, TWA are linked
to repolarization alternans (RA) at the cellular level. RA can
be measured from unipolar electrograms (UEGM) recorded
on the surface of the myocardium. UEGM contains both
local and far-field (remote) information. From the local
component, it is possible to estimate local depolarization
and repolarization times, and consequently the activation-
recovery interval (ARI) as a surrogate of action potential
duration (APD)[1]. The far-field component exhibits an ECG
like waveform, with a ST-segment and T-wave. Therefore,
UEGMs can be used to study both RA and TWA.
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RA are considered a factor of increased vulnerability to
ventricular-tachycardia/ventricular-fibrillation (VT/VF) and
sudden cardiac death (SCD)[2]. Increased repolarization dis-
persion across the heart has been demonstrated to be one pos-
sible mechanism of arrhythmogenisis in several experimental
works, generating the substrate needed for 2:1 block, re-entry
and life threatening cardiac arrhythmias[2][3]. Moreover,
clinical studies have also reported increased TWA magnitude
prior to the onset of spontaneous VT/VF[4][5]. This supports
the hypothesis that, in certain cases, the heart goes through
an intermediate state of increasing RA when transiting from
normal to abnormal rhythms.
These findings suggest that an early detection and con-
trol of RA could potentially suppress the arrhythmogenic
substrate and thus prevent VT/VF. Several experimental
and computational studies have explored the possibility of
applying dynamic pacing to control RA[6][7][8][9][10]. In a
recent porcine study, a method that successfully reduced RA
magnitude was proposed[11]. It consists in delivering early
refractory period pacing (RPP) from the right ventricle every
other beat with optimized amplitude, timing and polarity.
This novel therapy showed positive results in the whole heart,
while previous studies only showed limited spatial effec-
tiveness using single-site pacing[9][10]. Therefore, further
investigation on this procedure is needed. In particular, focus
should be placed on the effect and feasibility in the human
heart and on the underlying mechanisms.
In this study, we investigate the feasibility of APD modu-
lation using RPP in one human heart. Additionally, we inte-
grated the RRP protocol in the well-established OHara-Rudy
computational model of the human ventricular myocyte[12]
to investigate the underlying mechanisms and to test its
efficacy on the reduction of alternans in a population of
human calibrated models[13].
II. METHODS
A. In vivo data acquisition and analysis
In vivo UEGMs were acquired from one patient prior
to coronary artery bypass surgery[14]. The patient gave
informed consent and was enrolled in the study. The protocol
follows the ethical guidelines of the Declaration of Helsinki.
Cardiopulmonary bypass was temporarily commenced to
allow the surgeon to fit a multi electrode sock over the
epicardium of both ventricles as in previous studies[14][15].
The heart was then refilled and bypass discontinued in
order to allow the study to proceed with a normally beating
heart. UEGMs from 240 electrodes sampled at 2 KHz were
recorded from the multi-electrode sock. The protocol con-
sisted in 5 distinct parts with a duration of 40s each. Firstly,
steady state ventricular pacing (S1) was delivered from the
apex of the left ventricle (LV) at a cycle length (CL) of
500ms. During the second part, 10ms duration RPP stimula-
tion was additionally delivered at the nearest electrode, 50ms
after S1, every other beat, with positive polarity (RPP(+)).
These two parts were then repeated using refractory stimuli
with negative polarity (RPP(-)). The last part consisted in S1
steady state pacing only. Data were exported and analysed
off-line. Presence of TWA was analysed using the spectral
method as described previously[15]. It relies on spectral
analyses to quantify the magnitude of alternation on the T-
wave morphology at a frequency (f ) of 0.5 cycles per beat:
Kscore =
P − PN
σN
(1)
where P is the amplitude of the power spectrum at f = 0.5
and PN and σN are the mean and standard deviation of the
power spectrum at the noise band between f = [0.44 : 0.49].
B. In silico current clamp experiment
In silico investigations were based on the O’Hara-
Rudy (ORd) computation model of the human ventricular
myocyte[12]. The ORd model is considered the state-of-the-
art model of human ventricular electrophysiology, as it has
been extensively formulated and validated based on human
data. Simulations were performed at a CL of 500ms to mimic
the protocol used in the human patient. Firstly, 1000 beats
were generated to guarantee initial steady-state condition.
Afterwards, 500 beats were generated for each of the RPP
settings. RPP was delivered every other beat, 10ms after
S1 with a duration of 10ms. It was tested with positive
or negative polarities. Current clamp of 18 channels was
performed to elucidate the relevant ionic currents responsible
for RPP efficacy. The following channels were clamped
individually: INa (Na+ current), INaL (late Na+ current), Ito
(transient outward K+ current), ICaL (Ca2+ current through
the L-type Ca2+ channel), ICaNa (Na+ current through the
L-type Ca2+ channel), ICaK (K+ current through the L-
type Ca2+ channel), IKr (rapid delayed rectifier K+ cur-
rent), IKs (slow delayed rectifier K+ current), IK1 (inward
rectifier K+ current), INaCai (myoplasmic component of
Na+/Ca2+ exchange current), INaCass (subspace component
of the Na+/Ca2+ exchange current), INaK (Na+ ATPase
current), IpCa (sarcolemmal Ca2+ pump current), ICab (Ca2+
background current), IKb (K+ background current), INab
(Na+ background current), Jrel (Ca2+ release, via ryanodine
receptors, from jsr to myoplasm) and Jup (Ca2+ uptake, via
SERCA pump, from myoplasm to nsr). All simulations were
performed using MATLAB R© software.
C. In silico RPP on alternating models
A population of 87 calibrated human ventricular models
exhibiting alternans was used to access the efficacy of
this therapy on the reduction of alternans [13]. Simulations
were performed at CLs ranging from 600 to 350ms, in
50ms decrements. RPP was delivered every other beat with
negative or positive polarity and in the short or long beats.
The presence of APD alternans was defined as a difference
superior to 5ms between APD80 as in previous studies[13].
III. RESULTS
A. In vivo RPP analysis
Figure 1A shows an example of one epicardial electrogram
during RPP with positive polarity. Beats at which RPP(+)
stimulus was delivered showed a reduction in T-wave am-
plitude compared to the S1 beats. Analysis of TWA on 240
UGEMs was carried out using the spectral method. Figure 1C
shows the K-scores results for the periods of baseline steady
state pacing (No RPP), RPP with positive polarity (RPP
+) and RPP with negative polarity (RPP -). A significant
increase in the magnitude of TWA was observed (P<0.0001).
Results from the computational model (Fig 1B/D) showed a
decrease in APD due to a decrease in RT when positive RPP
was delivered.
Fig. 1. Effects of refractory period pacing. A: electrograms from in vivo
human ventricular epicardium. B: AP of the simulated ventricular myocyte
with RPP. Black for normal beats and red for beats with positive RPP. C:
K-score results for baseline steady state pacing (No RPP), RPP with positive
polarity (RPP +) and RPP with negative polarity (RPP -). D: APDs for AP
sequence in B.
B. In silico RPP effects on cellular physiology
The refractory pacing protocol was initially incorporated
in the original ORd model to evaluate its effects on APD
and channels behaviour on the normal myocyte. Results
show that APD could be either increased or decreased
depending on the stimulus polarity. A negatively charged
pacing increased the APD by 5ms. On the other hand, a
positively charged pacing decreased APD by almost 10ms.
There was no significant difference in APD during steady
state pacing. Figure 2A shows the action potential for a
S1 beat (black), a beat with a positive stimulus during the
RPP (red) and with a negative stimulus (blue). An increase
in the membrane potential due to the positive stimulus can
be clearly observed from 10ms after depolarization. ICaL
was substantially reduced due to voltage gate inactivation
Fig. 2. Effects of RPP on channels behaviour. Black: last beat before RPP
protocol. Red: last beat with RPP with positive polarity. Blue: last beat with
RPP with negative polarity. A: membrane potential (mV). B: Ca2+ current
through the L-type Ca2+ channel (ICaL). C: inward rectifier K+ current
(IK1). D: myoplasmic component of Na+/Ca2+ exchange current (INaCai).
E: intracellular Ca2+ transient (CaT)
Fig. 3. Results from the current clamp computational study. The vertical
axis shows the difference in APD90 between last beat with no RPP and
with RPP. Red represents results for RPP with positive polarity and blue
represent results for RPP with negative polarity. The first column (Control)
represent the behaviour of the model when no currents are clamped.
at high membrane potentials (Fig 2B), whilst the reverse
mode of the Na+/Ca2+ exchanger is promoted due to the
stimulation (Fig 2D). Despite no changes in magnitude, an
earlier activation of IK1 was observed (Fig 2C). The reduced
ICaL yielded a smaller Ca2+ release from the sarcoplasmic
reticulum, resulting in a decreased amplitude of the calcium
transient (CaT) (Fig 2E). The opposite occurs under negative
polarity RPP stimulation (Fig 2, right column), where the
reduction in membrane potential translates into the increase
of ICaL peak, the forward INaCai mode, increased amplitude
of CaT and a later IK1 activation.
Current clamp experiments were performed to further
dissect the role of each ionic current on RPP changes on
APD. Results are shown in Figure 3. In the case of positive
RPP (red), ICaL and IK1 are the main modulators of APD
shortening, as they clamp to control severely abolishes the
effect. INaCai has the opposite effect to these two currents,
due to the increase of its reverse mode. Interestingly, Ito
clamp revealed that its effects are also opposed and signif-
icantly smaller to those of the two main ionic mechanisms.
The same analysis holds for negative polarity RPP (Fig 3,
blue). The remain currents showed negligible effects.
C. In silico RPP on alternating models
A population of 87 ORd models calibrated to in vivo
human data and exhibiting RA[13] was used to assess the
efficiency of this protocol to reduce or abolish RA. RPP was
delivered in four different configurations: positive polarity on
the short beat (RPP S+), negative polarity on the short beat
(RPP S-), negative polarity on the long beat (RPP L-) and
positive polarity on the long beat (RPP L+). Figure 4 shows
alternans magnitude for APD for all the simulated configura-
tions. It can be observed that, as expected, this protocol can
both increase or decrease APD alternans depending on the
polarity of the stimulus and the beat in which it is delivered.
Figure 4 shows a significant reduction in APD alternans
magnitude for RPP S- (P<0.0023). The other configurations
resulted on a significant increase (P<0.0001).
Fig. 4. Effects of RPP in our population of 87 alternating computational
models. RPP was delivered in 4 different configurations: positive polarity
on the short beat (RPP S+), negative polarity on the short beat (RPP S-),
negative polarity on the long beat (RPP L-) and positive polarity on the
long beat (RPP L+).
IV. DISCUSSION
The aim of this work was to study the effects of RPP
in the human heart motivated by the promising results from
a porcine study[11]. We have delivered RPP to one human
patient and used the ORd model to study the underlying
mechanisms. To the extent of our knowledge this is the
first time that this type of pacing protocol is assessed in
the human. We also used a population of 87 models to test
the efficacy on reduction of RA. In vivo results showed an
increase in TWA during RPP. These indicates that electrical
stimulation during the refractory period affects repolarization
dynamics and can be potentially used to modulate repolar-
ization time. In silico experiments showed either a decreased
on APD with RPP+ or an increase on APD with a RPP-
. Current clamp protocols were carried out to dissect the
role of each ionic current and the physiologic mechanism
underling the RPP efficacy. An increase in the calcium
current through the L-type calcium channels increased the
amount of CaT in the cell which results in a prolonged
plateau phase. This means that the IK1 channels, which
play a major role in the repolarization process, are triggered
later and the APD is prolonged. In the case of a positive
stimulus, the opposite effect was observed. ICaL is reduced
and thus the membrane potential of phase 2 decays slightly
faster. Therefore, IK1 channels open sooner and the APD
is reduced. According to these results, it was expected that
delivering positively charged stimuli in the long beat or
negatively charged stimuli in the short beat would reduce
alternans. In the population of alternans models this was
confirmed for the negatively charged stimulus only. The
fact that RPP L+ did not reduce alternans in the alternans
model may due to the fact that these models have different
electrophysiological properties with respect to the normal
myocyte where RPP was originally tested. The results of this
study show that RPP can modulate repolarization dynamics,
and an appropriate pacing protocol should be established in
order to reduce or abolish repolarization alternans rather than
enhancing it.
V. CONCLUSION
In this study, we tested RPP in the human heart and
demonstrate its potentially for TWA modulation. In silico
experiments revealed that ICaL and IK1 are the main deter-
minants for the response to therapy and that RPP successfully
reduced APD alternans magnitude but the definition of
appropriate stimulation protocols is needed.
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